BACKGROUND: In recent years, vancomycin-resistant enterococci (VRE) have become one of major nosocomial pathogens in Korea. VRE infection presents as an increasingly difficult clinical problem in the treatment and management. The purpose of this study was to determine the clinical features, microbiologic characteristics, and genetic relatedenss of clinical VRE isolates which were collected from six university hospitals, distributed nationwide in Korea. In addition, we aimed to elucidate the possibility of VRE dissemination between hospitals. METHODS: During one year (January, 1999 to January, 2000), 107 clinically suspected VRE isolates were collected from six university hospitals and were subjected to vancomycin resistance genotyping by vanA, vanB, vanC1 and vanC2 PCR. Those 70 isolates with vanA genotype were examined antimicrobial susceptibility by agar dilution method. Pulsed-field gel electrophoreis (PFGE) were used for discriminating the genetic relatedness of VRE isolates. Clinical characteristics of the 61 patients with vanA VRE infection were analyzed for the identification of risk factors for VRE infection. RESULTS: Out of 107 clinical VRE isolates from six hospitals, 70 isolates (65.4%) were vanA genotype VRE (67 E. faecium, 3 E. faecalis). Their MIC90 of vancomycin, teicoplanin and ampicillin were >512 microgram mL, 512 microgrammL and >512 microgrammL respectively. The prevalance of high-level resistance to gentamicin and streptomycin were 96.9% and 78.1%, respectively. Prolonged hospital stay, cerebro-vascular disease, use of third generation cephalosporins, use of Foley catheter and levin tube were associated with VRE infection. 64 vanA VRE (61 E. faecium, 3 E. faecalis) had unique PFGE pattern within each hospital and showed no evidence of VRE transmission between hospitals. CONCLUSION: This study demonstrated the most common vancomycin resistance genotype among clini-cal VRE isolates in Korea were vanA type VRE. vanA genotype VRE had unique PFGE pattern within each hospital and showed no evidence of inter-hospital transmission. This study suggested that maintaining HICPAC guidelines, restricted vancomycin usage and periodic surveillance in patients with high risk factors are important in preventing the emergence and spread of VRE infection within hospitals.
Agar ; Ampicillin ; Catheters ; Cephalosporins ; Genotype ; Gentamicins ; Hospitals, University* ; Humans ; Korea ; Length of Stay ; Polymerase Chain Reaction ; Risk Factors ; Streptomycin ; Teicoplanin ; Vancomycin ; Vancomycin Resistance

The maintenance of peripheral immune tolerance and prevention of chronic inflammation and autoimmune disease require CD4+CD25+ T cells (regulatory T cells). The transcription factor Foxp3 is essential for the development of functional, regulatory T cells, which plays a prominent role in self-tolerance. Retroviral vectors can confer high level of gene transfer and transgene expression in a variety of cell types. Here we observed that following retroviral vector-mediated gene transfer of Foxp3, transductional Foxp3 expression was increased in the liver, lung, brain, heart, muscle, spinal cord, kidney and spleen. One day after vector administration, high levels of transgene and gene expression were observed in liver and lung. At 2 days after injection, transductional Foxp3 expression level was increased in brain, heart, muscle and spinal cord, but kidney and spleen exhibited a consistent low level. This finding was inconsistent with the increase in both CD4+CD25+ T cell and CD4+Foxp3+ T cell frequencies observed in peripheral immune cells by fluorescence-activated cell-sorting (FACS) analysis. Retroviral vector-mediated gene transfer of Foxp3 did not lead to increased numbers of CD4+CD25+ T cell and CD4+Foxp3+ T cell. These results demonstrate the level and duration of transductional Foxp3 gene expression in various tissues. A better understanding of Foxp3 regulation can be useful in dissecting the cause of regulatory T cells dysfunction in several autoimmune diseases and raise the possibility of enhancing suppressive functions of regulatory T cells for therapeutic purposes.
Animals ; Autoimmune Diseases ; Brain ; Gene Expression ; Heart ; Immune Tolerance ; Inflammation ; Kidney ; Liver ; Lung ; Mice ; Muscles ; Spinal Cord ; Spleen ; T-Lymphocytes ; T-Lymphocytes, Regulatory ; Transcription Factors ; Transgenes ; Zidovudine